PR Newswire (press release) In the IV-to-oral Phase 3 study, approximately 800 patients with Port II to Port IV CABP will be randomized to either a 400 mg IV dose of solithromycin or 400 mg IV dose of moxifloxacin . The investigator will switch patients to oral administration of ... and more »
Mail & Guardian Online But the results of a new study that were released earlier this year that stemmed from trials in different parts of Southern Africa showed that using rifapentine in conjunction with another up–and–coming TB drug, moxifloxacin , was just as effective as ...
PR Newswire (press release) In the IV-to-oral Phase 3 study, approximately 800 patients with Port II to Port IV CABP will be randomized to either a 400 mg IV dose of solithromycin or 400 mg IV dose of moxifloxacin . The investigator will switch patients to oral administration of ... and more »
PR Newswire (press release) In the IV-to-oral Phase 3 study, approximately 800 patients with Port II to Port IV CABP will be randomized to either a 400 mg IV dose of solithromycin or 400 mg IV dose of moxifloxacin . The investigator will switch patients to oral administration of ... and more »
AAP News (subscription) Polymyxin B-trimethoprim was just as effective and less expensive than moxifloxacin hydrochloride for the treatment of acute conjunctivitis, according to a randomized study of 124 patients ages 1-18 years. It has been suggested that topical ...
Renal and Urology News In a study of 1,292 men with AKI and 12,651 matched controls, current use of fluoroquinolones—particularly ciprofloxacin and moxifloxacin —was associated with a twofold increased risk of AKI compared with no use. n addition, concomitant use of an oral ...
AAP Grand Rounds (registration) Source: Williams L, Malhotra Y, Murante B, et al. A single-blinded randomized clinical trial comparing polymyxin B-trimethoprim and moxifloxacin for treatment of acute conjunctivitis in children. J Pediatr. 2013; 162( 4): 857– 861; doi: ...
